Pharmacists can learn about treatment of major depressive disorder.
A retrospective evaluation to assess whether medications for patients undergoing bariatric procedures are effectively optimized to ensure safe medication transitioning.
In 2015, American poison centers responded to more than 10,000 tricyclic antidepressant exposures. With this level of prevalence, pharmacists should be prepared to respond to questions regarding TCA toxicity.
A number of speakers at the American Pharmacists Association 2014 Annual Meeting in Orlando emphasized the importance of winning provider status for pharmacists.
This Continuing Education activity is supported by an educational grant from Alcon, Inc.
The FDA recently approved Ingrezza (valbenazine) for the treatment of adults with tardive dyskinesia.
Pharmacists are continuing to expand their role as health care providers with more direct patient care opportunities. Pharmacists working under the supervision of a physician can provide an annual wellness visit, which is an exam that focuses on the patient’s health, allowing them the opportunity to develop a personalized approach to health care and disease prevention.
The findings of a retrospective study suggest that timing of heart failure (HF)-related pharmacotherapy following a HF-related encounter has potential implications on subsequent healthcare costs.
Patients may find it difficult to distinguish between a cold and the flu, and pharmacists can help them determine if self treatment is appropriate.
Throughout a new graduate’s career, that provider status will become mainstream.
Fibromyalgia was related to a pattern of initial increase in utilization and costs, followed by a decrease 7 to 12 months after diagnosis.
In the health-system setting, pharmacists must often prioritize their attention to treating the most acute medical condition a patient presents with; however, it is important to also consider opportunities to prevent disease.
Multiple sclerosis (MS) is a disease of inflammatory demyelination of axons of the central nervous system that results in episodes of transient neurologic deficits, progressing to permanent neurologic deterioration over time.1 The cause of MS remains unclear, but it is thought to involve both genetic susceptibility and environmental triggers, possibly viral, which result in self-sustaining autoimmune dysfunction.
As administration of COVID-19 begins, pharmacies are preparing to vaccinate millions of people, not only once but twice.
Data aggregation partners can provide value in their ability to pull clinical information from both the HSSP and electronic health records.
NACDS anticipates another successful conference in Boston this August.
The US Food and Drug Administration has approved Allergan's supplemental New Drug Application to expand the approved use of their cephalosporin / beta-lactamase inhibitor combo antibiotic, AVYCAZ (ceftazidime and avibactam), to include the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) caused by the following susceptible Gram-negative microorganisms: Klebsiella pneumoniae, Enterobacter cloacae, Escherichia coli, Serratia marcescens, Proteus mirabilis, Pseudomonas aeruginosa, and Haemophilus influenzae in patients 18 years of age or older.
Even with many new developments over the past century, the coordinated use of blood glucose monitors, diabetes medications, and insulin to manage the disease may be too intricate for some patients.
Postoperative pain management presents a major challenge to patients and health care providers.
In addition to allopathic or prescription medications to manage depression stemming from this pandemic, there are integrative medicines, as well as health and wellness modalities, that can be used to improve mental health.
Before you start preparing for NAPLEX, familiarize yourself with what to expect for the exam.
Diabetes mellitus affects 23 million people in the United States. Adjusting for population age differences, survey data between 2004 and 2006 indicate that 6.6% of non-Hispanic whites, 7.5% of Asian Americans, 10.4% of Hispanics, and 11.8% of non-Hispanic blacks have diabetes mellitus.1 Totaling $174 billion in 2007, diabetes care accounts for 19% of total healthcare costs.
The 2010 health care reforms affect the daily practices of pharmacists, especially as generic drugs play an even greater role in the cost containment of health care for millions of Americans.
New care team models are springing up across the country.
Treatment advances have made many cancers a chronic disease rather than a terminal disease. Here is how one dedicated team works to coordinate care and work with patients.